Becker William C, Fiellin David A, Black Anne C, Kostovich Carol T, Kerns Robert D, Fraenkel Liana
Department of Veterans Affairs (VA) Connecticut Healthcare System, West Haven, CT;
J Rehabil Res Dev. 2016;53(1):127-36. doi: 10.1682/JRRD.2014.11.0285.
Guidelines on long-term opioid therapy recommend frequent reassessment of harm, efficacy, and misuse of these potentially harmful and sometimes ineffective medications. In primary care, there is a need for a brief, patient-reported instrument. This report details the initial steps in the development of such an instrument. An interdisciplinary team of clinician-scientists performed four discrete steps in this study: (1) conceptualization of the purpose and function of the instrument, (2) assembly of an item pool, (3) expert rating on which items were most important to include in the instrument, and (4) modification of expert-selected items based on a reading level check and cognitive interviews with patients. A diverse panel of 47 subject matter experts was presented with 69 items to rate on a 1-9 scale in terms of importance for inclusion in the instrument. The panel highly rated 37 items: 8 related to harm, 4 related to efficacy, and 25 related to misuse. These 37 items were then tested for patient comprehension and modified as needed. Next steps in development will include further item reduction, testing against a gold standard, and assessment of the instrument's effect on clinical outcomes.
长期阿片类药物治疗指南建议对这些潜在有害且有时无效的药物的危害、疗效和误用情况进行频繁重新评估。在初级保健中,需要一种简短的、由患者报告的工具。本报告详细介绍了开发此类工具的初步步骤。一个由临床医生 - 科学家组成的跨学科团队在本研究中进行了四个不同的步骤:(1)确定该工具的目的和功能的概念;(2)组建项目库;(3)专家对工具中应包含的最重要项目进行评分;(4)根据阅读水平检查和对患者的认知访谈对专家选定的项目进行修改。向由47名主题专家组成的多元化小组提供了69个项目,要求他们根据对纳入该工具的重要性在1 - 9分的量表上进行评分。该小组对37个项目给予了高度评价:8个与危害相关,4个与疗效相关,25个与误用相关。然后对这37个项目进行患者理解测试,并根据需要进行修改。开发的下一步将包括进一步减少项目、对照金标准进行测试以及评估该工具对临床结果的影响。